Mobley Research Laboratory: Department of Microbiology & Immunology: University of Michigan Medical School
 

Uropathogenic Escherichia coli

References

1. Kahlmeter, G., An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother, 2003. 51(1): p. 69-76.

2. Ronald, A., The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon, 2003. 49(2): p. 71-82.

3. Warren, J.W., Urinary Tract Infections: Molecular Pathogenesis and Clinical Management. 1 ed, ed. J.W. Warren. 1996, Washington, D.C.: ASM Press. 439.

4. Finer, G. and D. Landau, Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis, 2004. 4(10): p. 631-5.

5. Johnson, J.R. and T.A. Russo, Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol, 2005. 295(6-7): p. 383-404.

6. Johnson, J.R., Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev, 1991. 4(1): p. 80-128.

7. Manges, A.R., J.R. Johnson, B. Foxman, T.T. O'Bryan, K.E. Fullerton, and L.W. Riley, Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med, 2001. 345(14): p. 1007-13.

8. Gupta, K., T.M. Hooton, and W.E. Stamm, Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med, 2001. 135(1): p. 41-50.

9. Langermann, S., R. Mollby, J.E. Burlein, et al., Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis, 2000. 181(2): p. 774-8.

10. Langermann, S. and W.R. Ballou, Jr., Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis, 2001. 183 Suppl 1: p. S84-6.

11. Uehling, D.T., L.J. James, W.J. Hopkins, and E. Balish, Immunization against urinary tract infection with a multi-valent vaginal vaccine. J Urol, 1991. 146(1): p. 223-6.

12. Uehling, D.T., W.J. Hopkins, L.A. Dahmer, and E. Balish, Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection. J Urol, 1994. 152(6 Pt 2): p. 2308-11.

13. Uehling, D.T., W.J. Hopkins, L.J. James, and E. Balish, Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine. J Urol, 1994. 151(1): p. 214-6.

14. Uehling, D.T., W.J. Hopkins, E. Balish, Y. Xing, and D.M. Heisey, Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol, 1997. 157(6): p. 2049-52.

15. Uehling, D.T., W.J. Hopkins, J.E. Elkahwaji, D.M. Schmidt, and G.E. Leverson, Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol, 2003. 170(3): p. 867-9.

16. Mobley, H.L., D.M. Green, A.L. Trifillis, D.E. Johnson, G.R. Chippendale, C.V. Lockatell, B.D. Jones, and J.W. Warren, Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun, 1990. 58(5): p. 1281-9.

17. Welch, R.A., V. Burland, G. Plunkett, 3rd, et al., Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A, 2002. 99(26): p. 17020-4.

18. Snyder, J.A., B.J. Haugen, E.L. Buckles, C.V. Lockatell, D.E. Johnson, M.S. Donnenberg, R.A. Welch, and H.L. Mobley, Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection. Infect Immun, 2004. 72: p. 6373-6381.

19. Molloy, M.P., B.R. Herbert, M.B. Slade, T. Rabilloud, A.S. Nouwens, K.L. Williams, and A.A. Gooley, Proteomic analysis of the Escherichia coli outer membrane. Eur J Biochem, 2000. 267(10): p. 2871-81.

20. Unlu, M., M.E. Morgan, and J.S. Minden, Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis, 1997. 18(11): p. 2071-7.

21. Tielker, D., S. Hacker, R. Loris, M. Strathmann, J. Wingender, S. Wilhelm, F. Rosenau, and K.E. Jaeger, Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology, 2005. 151(Pt 5): p. 1313-23.

22. Wilhelm, S., J. Tommassen, and K.E. Jaeger, A novel lipolytic enzyme located in the outer membrane of Pseudomonas aeruginosa. J Bacteriol, 1999. 181(22): p. 6977-86.